Cited by 401Computational Drug Discovery MethodsChemical Synthesis and AnalysisEnzyme Structure and Function

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Tethering: Fragment-Based Drug Discovery

Erlanson, Daniel A., Wells, James A., Braisted, Andrew C.·2004·Annual Review of Biophysics and Biomolecular Structure

DOI 10.1146/annurev.biophys.33.110502.140409

Open this paper in CoChat — free account

Abstract

▪ Abstract The genomics revolution has provided a deluge of new targets for drug discovery. To facilitate the drug discovery process, many researchers are turning to fragment-based approaches to find lead molecules more efficiently. One such method, Tethering 1 , allows for the identification of small-molecule fragments that bind to specific regions of a protein target. These fragments can then be elaborated, combined with other molecules, or combined with one another to provide high-affinity drug leads. In this review we describe the background and theory behind Tethering and discuss its use in identifying novel inhibitors for protein targets including interleukin-2 (IL-2), thymidylate synthase (TS), protein tyrosine phosphatase 1B (PTP-1B), and caspases.

Integrity signals

Registry

Crossref · 10.1146/annurev.biophys.33.110502.140409

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B
Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D., Timkey, T., Garcia-Calvo, M. M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17907 · Cited by 2,089
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,045
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T. H., Bornmann, W. G., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,785
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,760
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090 · cited 1×
“These include proteases (27, 29, 30, 57, 59, 63), kinases (24, 74), and phosphatases (4, 28, 50), all classes of enzymes that are heavily pursued in the pharmaceutical industry.”
Background
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,048
Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors
Garcia-Calvo, M. M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., & Thornberry, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32608 · Cited by 980
On the attribution and additivity of binding energies
Jencks, W. P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4046 · Cited by 938
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 834
Unraveling hot spots in binding interfaces: progress and challenges
DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767

Show all 78 references

Research works printed but not linked: 1

Graczyk PP, 1999, Restor. Neurol. Neurosci., 14, 1

Sorted by citations

Items 101–200 of 401

High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
Craven, G. B., Affron, D. P., Allen, C. E., Matthies, S., Greener, J. G., Morgan, R. M. L., Tate, E. W., Armstrong, A., & Mann, D. J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201711825 · Cited by 73
Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor
Buck, E. A., & Wells, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500016102 · Cited by 73
Self-citation
Sensitized Detection of Inhibitory Fragments and Iterative Development of Non‐Peptidic Protease Inhibitors by Dynamic Ligation Screening
Schmidt, M. F., Isidro‐Llobet, A., Lisurek, M., El‐Dahshan, A., Tan, J., Hilgenfeld, R., & Rademann, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200704594 · Cited by 73
On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry
Long, M. J. C., Poganik, J. R., & Aye, Y. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12608 · Cited by 73
α-Helix mimetics as inhibitors of protein–protein interactions
Saraogi, I., & Hamilton, A. D. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361414 · Cited by 70
Plucking the high hanging fruit: A systematic approach for targeting protein–protein interactions
Raj, M., Bullock, B. N., & Arora, P. S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.023 · Cited by 66
DNA-encoded chemical libraries
Scheuermann, J., Dumelin, C. E., Melkko, S., & Neri, D. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.05.018 · Cited by 66
The Three-Dimensional Structures of Tick Carboxypeptidase Inhibitor in Complex with A/B Carboxypeptidases Reveal a Novel Double-headed Binding Mode
Arolas, J. L., Popowicz, G. M., Lorenzo, J., Sommerhoff, C. P., Huber, R., Avilés, F. X., & Holak, T. A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.05.015 · Cited by 65
Progress in targeting RAS with small molecule drugs
McCormick, F. P. (2019) · Biochemical Journal · doi:10.1042/bcj20170441 · Cited by 64
Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate
Dawson, A., Gibellini, F., Sienkiewicz, N., Tulloch, L. B., Fyfe, P. K., McLuskey, K., Fairlamb, A. H., & Hunter, W. N. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05332.x · Cited by 63
Virtual Screening of Human 5-Aminoimidazole-4-carboxamide Ribonucleotide Transformylase against the NCI Diversity Set by Use of AutoDock to Identify Novel Nonfolate Inhibitors
Li, C., Xu, L., Wolan, D. W., Wilson, I. A., & Olson, A. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049504o · Cited by 63
Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly
Erlanson, D. A., & Hansen, S. K. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.010 · Cited by 61
Self-citation
Probing secondary interactions in biomolecular recognition by dynamic combinatorial chemistry
Ulrich, S., & Dumy, P. (2014) · Chemical Communications · doi:10.1039/c4cc00263f · Cited by 60
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Wu, H., Yao, H., He, C., Jia, Y., Zhu, Z., Xu, S., Li, D., & Xu, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.019 · Cited by 63
Practical Aspects of NMR-Based Fragment Screening
Lepre, C. A. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381274-2.00009-1 · Cited by 60
Profiling the Dynamic Interfaces of Fluorinated Transcription Complexes for Ligand Discovery and Characterization
Pomerantz, W. C. K., Wang, N., Lipinski, A. K., Wang, R., Cierpicki, T., & Mapp, A. K. (2012) · ACS Chemical Biology · doi:10.1021/cb3002733 · Cited by 60
Affinity-based, biophysical methods to detect and analyze ligand binding to recombinant proteins: Matching high information content with high throughput
Holdgate, G. A., Anderson, M., Edfeldt, F., & Geschwindner, S. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.06.024 · Cited by 60
BindingDB Entry 50026483: Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
BindingDB (2010) · UC San Diego · doi:10.7270/q2t43swr · Cited by 60
Fragments: where are we now?
Osborne, J., Panova, S., Rapti, M., Urushima, T., & Jhoti, H. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190694 · Cited by 58
Fragment Deconstruction of Small, Potent Factor Xa Inhibitors: Exploring the Superadditivity Energetics of Fragment Linking in Protein–Ligand Complexes
Nazaré, M., Matter, H., Will, D. W., Wagner, M., Urmann, M., Czech, J., Schreuder, H., Bauer, A., Ritter, K., & Wehner, V. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201107091 · Cited by 59
Tailored therapeutics based on 1,2,3-1 H -triazoles: a mini review
Prasher, P., & Sharma, M. (2019) · MedChemComm · doi:10.1039/c9md00218a · Cited by 62
Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange
Nnadi, C. I., Jenkins, M. L., Gentile, D. R., Bateman, L. A., Zaidman, D., Balius, T. E., Nomura, D. K., Burke, J. E., Shokat, K. M., & London, N. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00399 · Cited by 60
Direct and Propagated Effects of Small Molecules on Protein–Protein Interaction Networks
Cesa, L. C., Mapp, A. K., & Gestwicki, J. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00119 · Cited by 63
Assessment of Additive/Nonadditive Effects in Structure−Activity Relationships: Implications for Iterative Drug Design
Patel, Y., Gillet, V. J., Howe, T. J., Pastor, J., Oyarzábal, J., & Willett, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801070q · Cited by 58
Screening for molecular glues – Challenges and opportunities
Holdgate, G. A., Bardelle, C., Berry, S. K., Lanne, A., & Cuomo, M. E. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.12.008 · Cited by 60
Conduits of Life’s Spark: A Perspective on Ion Channel Research since the Birth of Neuron
Isacoff, E. Y., Jan, L. Y., & Minor, D. L. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.040 · Cited by 57
Modulating Protein-Protein Interactions: From Structural Determinants of Binding to Druggability Prediction to Application
Metz, A., Ciglia, E., & Gohlke, H. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802651553 · Cited by 59
Ligand‐Based Vascular Targeting of Disease
Rybak, J., Trachsel, E., Scheuermann, J., & Neri, D. (2006) · ChemMedChem · doi:10.1002/cmdc.200600181 · Cited by 57
Exploitation of Latent Allostery Enables the Evolution of New Modes of MAP Kinase Regulation
Coyle, S. M., Flores, J. A., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.07.019 · Cited by 54
Dynamic template-assisted strategies in fragment-based drug discovery
Schmidt, M. F., & Rademann, J. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.06.001 · Cited by 53
Exploiting Neighboring‐Group Interactions for the Self‐Selection of a Catalytic Unit
Gasparini, G. M., Prins, L. J., & Scrimin, P. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703857 · Cited by 51
NMR-Fragment Based Virtual Screening: A Brief Overview
Singh, M., Tam, B., & Akabayov, B. (2018) · Molecules · doi:10.3390/molecules23020233 · Cited by 54
Identifying Allosteric Binding Sites in Proteins with a Two-State Go Model for Novel Allosteric Effector Discovery
Qi, Y., Wang, Q., Tang, B., & Lai, L. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300395h · Cited by 51
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
McAulay, K., Bilsland, A. E., & Bon, M. (2022) · Pharmaceuticals · doi:10.3390/ph15111366 · Cited by 54
Diversity of Allosteric Regulation in Proteases
Merdanovic, M., Mönig, T., Ehrmann, M., & Kaiser, M. (2012) · ACS Chemical Biology · doi:10.1021/cb3005935 · Cited by 50
Selective Identification of Cooperatively Binding Fragments in a High‐Throughput Ligation Assay Enables Development of a Picomolar Caspase‐3 Inhibitor
Schmidt, M. F., El‐Dahshan, A., Keller, S., & Rademann, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901647 · Cited by 50
Allosteric small molecule modulators of nuclear receptors
Meijer, F. A., de Gevel, I. A. L.-V., de Vries, R. M. J. M., & Brunsveld, L. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.01.022 · Cited by 50
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface
Wojcik, J. B., Lamontanara, A. J., Grabe, G. J., Koide, A., Akin, L. R., Gerig, B., Hantschel, O. D., & Koide, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707901 · Cited by 49
Synthesis of azide-alkyne fragments for ‘click’ chemical applications; formation of oligomers from orthogonally protected trialkylsilyl-propargyl azides and propargyl alcohols
Montagnat, O. D., Lessène, G., & Hughes, A. B. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.07.131 · Cited by 49
Allosteric regulation of protease activity by small molecules
Shen, A. (2010) · Molecular BioSystems · doi:10.1039/c003913f · Cited by 50
Quantitative Assessment of Affinity Selection Performance by Using DNA‐Encoded Chemical Libraries
Sannino, A., Gabriele, E., Bigatti, M., Mulatto, S., Piazzi, J., Scheuermann, J., Neri, D., Donckèle, E. J., & Samain, F. (2018) · ChemBioChem · doi:10.1002/cbic.201800766 · Cited by 48
Kinetic Template‐Guided Tethering of Fragments
Nonoo, R. H., Armstrong, A., & Mann, D. J. (2012) · ChemMedChem · doi:10.1002/cmdc.201200404 · Cited by 47
DNA‐Encoded Chemical Libraries: A Tool for Drug Discovery and for Chemical Biology
Scheuermann, J., & Neri, D. (2010) · ChemBioChem · doi:10.1002/cbic.201000066 · Cited by 47
Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs
Srinivasan, B., Tonddast‐Navaei, S., Roy, A., Zhou, H., & Skolnick, J. (2018) · Medicinal Research Reviews · doi:10.1002/med.21538 · Cited by 46
The Overlap of Small Molecule and Protein Binding Sites within Families of Protein Structures
Davis, F. P., & Šali, A. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000668 · Cited by 47
Library screening by fragment‐based docking
Danzhi Huang, A., & Caflisch, A. (2009) · Journal of Molecular Recognition · doi:10.1002/jmr.981 · Cited by 45
Inhibition of the Calcineurin-NFAT Interaction by Small Organic Molecules Reflects Binding at an Allosteric Site
Kang, S., Li, H., Rao, A., & Hogan, P. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502247200 · Cited by 48
From Concepts to Inhibitors: A Blueprint for Targeting Protein–Protein Interactions
Hong, S. H., Nguyễn, T. T., Ongkingco, J. F., Nazzaro, A., & Arora, P. S. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00046 · Cited by 45
Evolution of Pyrrolysyl-tRNA Synthetase: From Methanogenesis to Genetic Code Expansion
Koch, N. G., & Budiša, N. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00031 · Cited by 44
Combined Mass Spectrometry and Dynamic Chemistry Approach to Identify Metalloenzyme Inhibitors
Liénard, B. M. R., Selevsek, N., Oldham, N. J., & Schofield, C. J. (2007) · ChemMedChem · doi:10.1002/cmdc.200600250 · Cited by 43
A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand
Sun, Q., Phan, J., Friberg, A., Camper, D. V., Olejniczak, E. T., & Fesik, S. W. (2014) · Journal of Biomolecular NMR · doi:10.1007/s10858-014-9849-8 · Cited by 42
Druggability predictions: methods, limitations, and applications
Barril, X. (2012) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1134 · Cited by 43
Covalent Small Molecule Inhibitors of Ca2+-Bound S100B
Cavalier, M. C., Pierce, A. D., Wilder, P. T., Alasady, M. J., Hartman, K. G., Neau, D. B., Foley, T. L., Jadhav, A., Maloney, D. J., Simeonov, A. M., et al. (2014) · Biochemistry · doi:10.1021/bi5005552 · Cited by 42
Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery
Huang, R., & Leung, I. K. H. (2016) · Molecules · doi:10.3390/molecules21070910 · Cited by 40
Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors via Tethering in Situ Click Chemistry
Wang, Y., Zhu, J., & Zhang, L. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01237 · Cited by 42
Developing Small‐Molecule Inhibitors of HECT‐Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities
Chen, D., Gehringer, M., & Lorenz, S. (2018) · ChemBioChem · doi:10.1002/cbic.201800321 · Cited by 43
Targeting allosteric regulation of cancer metabolism
Kremer, D. M., & Lyssiotis, C. A. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-00997-6 · Cited by 43
The role of a Lewis acid in the Nenitzescu indole synthesis
VELEZHEVA, V. S., Sokolov, A. I., Kornienko, A. G., Lyssenko, K. A., Nelyubina, Y. V., Godovikov, I. A., Peregudov, А. S., & Миронов, А. Ф. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.09.087 · Cited by 40
Identification of novel fragment compounds targeted against the pY pocket of v‐Src SH2 by computational and NMR screening and thermodynamic evaluation
Taylor, J. D., Gilbert, P. J., Williams, M. A., Pitt, W. R., & Ladbury, J. E. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21369 · Cited by 39
Applications of Reactive Cysteine Profiling
Backus, K. M. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_120 · Cited by 39
Discovery of allosteric binding sites by crystallographic fragment screening
Krojer, T. J., Fraser, J. S., & von Delft, F. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.08.004 · Cited by 37
Multivalency-Assisted Control of Intracellular Signaling Pathways: Application for Ubiquitin- Dependent N-End Rule Pathway
Sriram, S. M., Banerjee‬‬‬‬‬‬‬‬‬, R., Kane, R. S., & Kwon, Y. T. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.012 · Cited by 37
Covalent Proximity Inducers
London, N. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00570 · Cited by 37
FP tethering: a screening technique to rapidly identify compounds that disrupt protein–protein interactions
Lodge, J. M., Rettenmaier, T. J., Wells, J. A., Pomerantz, W. C. K., & Mapp, A. K. (2014) · MedChemComm · doi:10.1039/c3md00356f · Cited by 35
Self-citation
The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1
Xu, X., Chen, Y., Fu, Q., Ni, D., Zhang, J., Li, X., & Lu, S. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1553167 · Cited by 37
Library Design Strategies To Accelerate Fragment‐Based Drug Discovery
Troelsen, N. S., & Clausen, M. H. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202000584 · Cited by 35
Site-specific Disulfide Capture of Agonist and Antagonist Peptides on the C5a Receptor
Buck, E. A., Bourne, H. R., & Wells, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400500200 · Cited by 35
Self-citation
Molecular docking study of the interactions between the thioesterase domain of human fatty acid synthase and its ligands
Cheng, F., Wang, Q., Chen, M., Quiocho, F. A., & Ma, J. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21615 · Cited by 35
Progress in discovery of small-molecule modulators of protein–protein interactions via fragment screening
Magee, T. V. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.089 · Cited by 36
Impact of a Central Scaffold on the Binding Affinity of Fragment Pairs Isolated from DNA‐Encoded Self‐Assembling Chemical Libraries
Bigatti, M., Corso, A. D., Vanetti, S., Cazzamalli, S., Rieder, U., Scheuermann, J., Neri, D., & Sladojevich, F. (2017) · ChemMedChem · doi:10.1002/cmdc.201700569 · Cited by 34
X-ray Screening of an Electrophilic Fragment Library and Application toward the Development of a Novel ERK 1/2 Covalent Inhibitor
Denis, J. D. S., Chessari, G., Cleasby, A., Cons, B. D., Cowan, S., Dalton, S. E., East, C., Murray, C. W., O’Reilly, M., Peakman, T. M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01044 · Cited by 34
Mimicking damaged DNA with a small molecule inhibitor of human UNG2
Krosky, D. J., Bianchet, M. A., Seiple, L. A., Chung, S., Amzel, L. M., & Stivers, J. T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl747 · Cited by 34
Hybrid Organic–Inorganic Inhibitors of a PDZ Interaction that Regulates the Endocytic Fate of CFTR
Kundu, R., Cushing, P. R., Popp, B. V., Zhao, Y., Madden, D. R., & Ball, Z. T. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202291 · Cited by 33
Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement
Fearon, D., Powell, A. J., Douangamath, A., Dias, A. M. M., Tomlinson, C. W. E., Balcomb, B. H., Aschenbrenner, J. C., Aimon, A., Barker, I. A., Bertram, F., et al. (2024) · Applied Research · doi:10.1002/appl.202400192 · Cited by 33
Solid‐phase glycan isolation for glycomics analysis
Yang, S., & Zhang, H. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200045 · Cited by 32
Loop-Swapped Chimeras of the Agouti-Related Protein and the Agouti Signaling Protein Identify Contacts Required for Melanocortin 1 Receptor Selectivity and Antagonism
Patel, M. P., Fabersunne, C. C., Yang, Y., Kaelin, C. B., Barsh, G. S., & Millhauser, G. L. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.054 · Cited by 32
Direct optical detection in fragment-based screening
Pröll, F., Fechner, P., & Proll, G. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2477-y · Cited by 32
Sensibilisierte Detektion inhibitorischer Fragmente und iterative Entwicklung nicht‐peptidischer Proteaseinhibitoren durch dynamisches Ligationsscreening
Schmidt, M. F., Isidro‐Llobet, A., Lisurek, M., El‐Dahshan, A., Tan, J., Hilgenfeld, R., & Rademann, J. (2008) · Angewandte Chemie · doi:10.1002/ange.200704594 · Cited by 31
Review: nanoparticles in drug delivery for the treatment of cancer.
Arayne, M. S., & Sultana, N. (2006) · PubMed · Cited by 31
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Forrest, I., & Parker, C. G. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200098 · Cited by 31
Small Molecule Targeting of Protein–Protein Interactions through Allosteric Modulation of Dynamics
Cossins, B. P., & Lawson, A. D. G. (2015) · Molecules · doi:10.3390/molecules200916435 · Cited by 29
In silico fragment-based drug design
Konteatis, Z. D. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.523697 · Cited by 29
Application of mass spectrometry technologies for the discovery of low-molecular weight modulators of enzymes and protein–protein interactions
Zehender, H., & Mayr, L. M. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.031 · Cited by 29
Temperature-sensitive protein–DNA dimerizers
Hauschild, K. E., Metzler, R. E., Arndt, H., Moretti, R., Raffaelle, M., Dervan, P. B., & Ansari, A. Z. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501289102 · Cited by 29
Covalent inhibition of pro-apoptotic BAX
McHenry, M. W., Shi, P., Camara, C. M., Cohen, D. T., Rettenmaier, T. J., Adhikary, U., Gygi, M. A., Yang, K., Gygi, S. P., Wales, T. E., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01537-6 · Cited by 28
Self-citation
Recent advances in DNA-encoded dynamic libraries
Shi, B., Zhou, Y., & Li, X. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00007e · Cited by 28
Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods
Kroon, E., Schulze, J. O., Süß, E., Camacho, C. J., Biondi, R. M., & Dömling, A. S. S. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506310 · Cited by 27
Conservation of coactivator engagement mechanism enables small-molecule allosteric modulators
Henderson, A. R., Henley, M. J., Foster, N., Peiffer, A. L., Beyersdorf, M. S., Stanford, K., Sturlis, S. M., Linhares, B. M., Hill, Z. B., Wells, J. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806202115 · Cited by 27
Self-citation
Fragment-Based Drug Discovery: Small Fragments, Big Impact − Success Stories of Approved Oncology Therapeutics
Khedkar, N. R., Sindkhedkar, M. D., & Joseph, A. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108197 · Cited by 27
Using Fragment-Based Approaches to Discover New Antibiotics
Lamoree, B., & Hubbard, R. E. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218773034 · Cited by 26
Biophysical screening in fragment-based drug design: a brief overview
Robson‐Tull, J. (2018) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzy015 · Cited by 27
Structural analysis of caspase-1 inhibitors derived from Tethering
O'Brien, T., Fahr, B. J., Sopko, M. M., Lam, J. W., Waal, N. D., Raimundo, B. C., Purkey, H. E., Pham, P., & Romanowski, M. J. (2005) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309105010109 · Cited by 26
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
Togre, N. S., Vargas, A. M., Bhargavi, G., Mallakuntla, M. K., & Tiwari, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810669 · Cited by 25
Computer-aided design and discovery of protein–protein interaction inhibitors as agents for anti-HIV therapy
Veselovsky, A. V., Zharkova, M. S., Poroikov, V., & Nicklaus, M. C. (2014) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2014.898689 · Cited by 25
Fragment-Based Lead Discovery
Davis, B. J., & Roughley, S. D. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.07.002 · Cited by 27
Rapid identification of improved protein ligands using peptoid microarrays
Lim, H., Reddy, M. M., Xiao, X., Wilson, J., Wilson, R. W., Connell, S., & Kodadek, T. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.153 · Cited by 25
Evolution of direct RAS inhibitors: from undruggable target to clinical breakthroughs
Wang, X., Wu, J., Xiao, A., Wang, J., & Tian, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02364-0 · Cited by 25
Advances of bioorthogonal coupling reactions in drug development
Zhan, F., Zhu, J., Xie, S., Xu, J., & Xu, S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115338 · Cited by 24
Synthesis of non-equivalent diamides and amido-esters via Pd-catalysed carbonylation
Ge, Y., Huang, W.-H., Ahrens, S., Spannenberg, A., Jackstell, R., & Beller, M. (2023) · Nature Synthesis · doi:10.1038/s44160-023-00411-6 · Cited by 24
Chapter 28 Fragment-Based Lead Discovery
Congreve, M., Murray, C. W., Carr, R. A. E., & Rees, D. C. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42028-0 · Cited by 24

Authors: Erlanson, D. A., Wells, J. A., & Braisted, A. C.
Affiliations: Sunesis (United States) (US)
ORCID: Erlanson, Daniel A.
Wells, James A.
Venue: Annual Review of Biophysics and Biomolecular Structure
Publisher: Annual Reviews
Published: 2004-06-09
Volume: 33
Issue: 1
Pages: 199-223
ISSN: 1056-8700 (ISSN-L)
1545-4266
DOI: 10.1146/annurev.biophys.33.110502.140409
OpenAlex: W2138958920
Cited by: 385
References: 78
Citations by year: 2026: 5 · 2025: 7 · 2024: 17 · 2023: 16 · 2022: 17 · 2021: 8 · 2020: 17 · 2019: 17 · 2018: 21 · 2017: 6 · 2016: 18 · 2015: 21 · 2014: 23 · 2013: 11 · 2012: 29
FWCI: 1.77
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Biophysics and Biomolecular Structure (publishedVersion)
PubMed (publishedVersion)
Funders: Sunesis
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords: tethering, fragment-based drug discovery, small-molecule fragments, protein-ligand binding, lead compound identification, interleukin-2, thymidylate synthase, PTP1B, caspases, protein inhibitors
MeSH terms: Binding Sites, Peptide Fragments, Protein Binding, Proteins, Drug Design, Protein Interaction Mapping, Protein Array Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tethering: Fragment-Based Drug Discovery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks